Refresh

Ajanta Pharma Ltd. - Research Center

532331 AJANTPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

3,971.12 3,411.27 3,140.64 2,718.59 2,196.42
Expenses

Material consumed

1,128.17 1,071.74 887.01 767.42 698.49

Manufacturing expenses

66.44 65.53 54.09 43.42 38.56

Personnel expenses

834.16 720.41 585.87 498.11 437.82

Selling expenses

4.49 5.02 4.78 1.62 1.40

Adminstrative expenses

818.43 849.29 718.00 491.11 487.37

Expenses capitalised

- - - - -

Cost of sales

2,851.69 2,711.99 2,249.75 1,801.68 1,663.64

Operating profit

1,119.43 699.28 890.89 916.91 532.78

Other recurring income

116.48 132.75 139.73 103.57 184.20

Adjusted PBDIT

1,235.91 832.03 1,030.62 1,020.48 716.98

Financial expenses

6.80 5.23 9.12 6.90 9.10

Depreciation

132.16 126.95 120.96 111.49 91.29

Other write offs

- - - - -

Adjusted PBT

1,096.95 699.85 900.54 902.09 616.59

Tax charges

289.71 141.13 180.68 226.45 171.54

Adjusted PAT

807.24 558.72 719.86 675.64 445.05

Non recurring items

- - - - -3.92

Other non cash adjustments

- - - - -

Reported net profit

807.24 558.72 719.86 675.64 441.13

Earnigs before appropriation

3,896.53 3,253.70 2,845.69 2,241.15 1,681.43

Equity dividend

642.17 89.69 82.21 51.26 110.96

Preference dividend

- - - - -

Dividend tax

- - - 31.64 2.48

Retained earnings

3,254.36 3,164.01 2,763.48 2,158.25 1,567.99
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com